Parallax Volatility Advisers, L.P. - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$5,107,000
-36.0%
44,188
-46.1%
0.00%
-40.0%
Q3 2020$7,981,000
+23.5%
82,031
+55.9%
0.01%
-28.6%
Q2 2020$6,462,000
+218.2%
52,608
+127.7%
0.01%
+133.3%
Q1 2020$2,031,000
+230.8%
23,100
+290.5%
0.00%
Q4 2019$614,000
-90.0%
5,916
-88.9%
0.00%
-100.0%
Q3 2019$6,133,000
+699.6%
53,317
+1098.4%
0.01%
+600.0%
Q2 2019$767,000
-92.1%
4,449
-92.3%
0.00%
-90.9%
Q1 2019$9,724,000
+557.0%
57,691
+279.5%
0.01%
+450.0%
Q4 2018$1,480,000
+22.9%
15,200
+118.1%
0.00%
+100.0%
Q3 2018$1,204,000
+692.1%
6,968
+540.4%
0.00%
Q2 2018$152,000
-99.1%
1,088
-99.2%
0.00%
-100.0%
Q4 2016$16,040,000
+35.3%
143,533
+60.7%
0.03%
+40.9%
Q3 2016$11,857,000
+1194.4%
89,333
+793.3%
0.02%
+1000.0%
Q2 2016$916,000
-86.2%
10,000
-89.5%
0.00%
-85.7%
Q4 2015$6,646,00095,6900.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders